RBM4 and cancer: Our results demonstrated that depletion of RBM4 promoted multiple cancer cell senescence, as judged by increased SA-β-gal activity, resulting in cell cycle arrest, inhibition of cell proliferation, and alterations at protein levels of senescence related markers.